New balloon technique may lower heart risks after stenting
NCT ID NCT04242134
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether using a drug-coated balloon (DCB) instead of a standard balloon for the side branch of a heart artery after stenting can reduce the chance of major heart problems like heart attack or death within one year. About 784 adults with coronary artery disease and true bifurcation lesions (where the main artery splits) are taking part. The goal is to see if the DCB approach leads to fewer heart-related events.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nanjing First Hospital
Nanjing, Jiangsu, 210006, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Software-Guided heart procedures: a new standard for coronary care?
- Heart patients may stay active longer with coach calls and group support
- Sitting less could be a lifeline for frail hearts – a new trial tests a simple program
- Can balloon timing make or break heart artery success?
- Can we predict which heart aneurysms will grow?
- Can a higher dose of adenosine sharpen heart scans?